AI/ML Innovations Inc AIMLF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AIMLF is a good fit for your portfolio.
News
-
AI/ML Innovations Inc.’s Health Gauge Unveils 'The Pulse Guru', its Second Advanced Neural Network Based Commercial Product
-
AI/ML Innovations Inc. Announces Settlement of Debt with ThreeD Capital Inc.
-
AI/ML Innovations Inc.’s Health Gauge Launches "Follow Your Heart": A Revolutionary Non-Invasive Blood Pressure Measurement Solution
-
AI/ML Innovations Inc. Welcomes Esmat Naikyar as Interim Chief Product Officer to Drive Healthcare Innovation
-
AI/ML Innovations Inc.'s Health Gauge Seeking FDA Approval for Its Patented Blood Pressure Measurement Technology
-
AI/ML Innovations Inc. Appoints Dr. David Cramb, Dean of the Faculty of Science at Toronto Metropolitan University, as Chair of the Company's Inaugural Science and Product Advisory Board
-
AI/ML Innovations Inc. Presents A Fireside Chat and a Company Update
-
AI/ML Innovations Inc. Unveils Micropayment Pilot Program in Collaboration With TODAQ Micro and Health Gauge Biometrics
Trading Information
- Previous Close Price
- $0.05
- Day Range
- $0.06–0.07
- 52-Week Range
- $0.05–0.20
- Bid/Ask
- $0.05 / $0.07
- Market Cap
- $4.56 Mil
- Volume/Avg
- 52,471 / 70,413
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
AI/ML Innovations Inc has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence and machine learning, with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. The company has strategic partnerships with Health Gauge, Tech2Health and other planned accretive investments.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.aiml-innovations.com
Valuation
Metric
|
AIMLF
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 11.02 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
AIMLF
Financial Strength
Metric
|
AIMLF
|
---|---|
Quick Ratio | 0.23 |
Current Ratio | 0.27 |
Interest Coverage | −30.14 |
Quick Ratio
AIMLF
Profitability
Metric
|
AIMLF
|
---|---|
Return on Assets (Normalized) | −99.31% |
Return on Equity (Normalized) | −269.41% |
Return on Invested Capital (Normalized) | −503.61% |
Return on Assets
AIMLF
Health Information Services Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Chmjplq | $41.4 Bil | |
VEEV
| Veeva Systems Inc Class A | Djpxnpydzh | Yvqk | $37.4 Bil | |
MTHRF
| M3 Inc | — | Hbdwyhq | $9.7 Bil | |
MTHRY
| M3 Inc ADR | — | Rnblbpr | $9.7 Bil | |
PMCUF
| Pro Medicus Ltd | — | Kpbvyp | $7.1 Bil | |
HQY
| HealthEquity Inc | — | Ysjljp | $7.0 Bil | |
RCM
| R1 RCM Inc | — | Hqjj | $5.4 Bil | |
DOCS
| Doximity Inc Class A | — | Gmvsdb | $5.0 Bil | |
TXG
| 10x Genomics Inc Ordinary Shares - Class A | — | Xqv | $4.5 Bil | |
EVH
| Evolent Health Inc Class A | — | Lyykf | $3.7 Bil |